Group One Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,800
| Closed | -$69K | – | 9230 |
|
|
2021
Q4 | $69K | Buy |
14,800
+11,700
| +377% | +$48.8K | ﹤0.01% | 6071 |
|
|
2021
Q3 | $12K | Sell |
3,100
-15,400
| -83% | -$61.1K | ﹤0.01% | 7440 |
|
|
2021
Q2 | $79K | Buy |
18,500
+17,000
| +1,133% | +$72.8K | ﹤0.01% | 6186 |
|
|
2021
Q1 | $6K | Buy |
1,500
+700
| +88% | +$3.86K | ﹤0.01% | 7222 |
|
|
2020
Q4 | $3K | Buy |
800
+500
| +167% | +$2.14K | ﹤0.01% | 6218 |
|
|
2020
Q3 | $1K | Sell |
300
-14,000
| -98% | -$58K | ﹤0.01% | 6005 |
|
|
2020
Q2 | $61K | Buy |
14,300
+1,200
| +9% | +$7.31K | ﹤0.01% | 4240 |
|
|
2020
Q1 | $55K | Buy |
13,100
+9,200
| +236% | +$58.1K | ﹤0.01% | 3654 |
|
|
2019
Q4 | $15K | Sell |
3,900
-8,500
| -69% | -$50.2K | ﹤0.01% | 4475 |
|
|
2019
Q3 | $109K | Buy |
12,400
+10,300
| +490% | +$97.3K | ﹤0.01% | 3507 |
|
|
2019
Q2 | $19K | Buy |
+2,100
| New | +$15.8K | ﹤0.01% | 4209 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$1K | – | 5855 |
|
|
2018
Q4 | $1K | Sell |
100
-9,500
| -99% | -$143K | ﹤0.01% | 4788 |
|
|
2018
Q3 | $193K | Buy |
9,600
+8,600
| +860% | +$225K | ﹤0.01% | 3040 |
|
|
2018
Q2 | $29K | Sell |
1,000
-6,100
| -86% | -$188K | ﹤0.01% | 4236 |
|
|
2018
Q1 | $211K | Sell |
7,100
-5,900
| -45% | -$190K | ﹤0.01% | 2758 |
|
|
2017
Q4 | $418K | Buy |
13,000
+500
| +4% | +$16.3K | ﹤0.01% | 2402 |
|
|
2017
Q3 | $435K | Sell |
12,500
-21,200
| -63% | -$682K | ﹤0.01% | 2194 |
|
|
2017
Q2 | $1M | Sell |
33,700
-29,400
| -47% | -$842K | 0.01% | 1450 |
|
|
2017
Q1 | $1.88M | Buy |
63,100
+51,000
| +421% | +$1.3M | 0.02% | 904 |
|
|
2016
Q4 | $212K | Sell |
12,100
-9,300
| -43% | -$178K | ﹤0.01% | 2389 |
|
|
2016
Q3 | $509K | Buy |
21,400
+4,600
| +27% | +$86.7K | 0.01% | 1808 |
|
|
2016
Q2 | $269K | Buy |
16,800
+16,100
| +2,300% | +$289K | ﹤0.01% | 2201 |
|
|
2016
Q1 | $15K | Buy |
+700
| New | +$12.5K | ﹤0.01% | 3889 |
|
|
2015
Q4 | – | Sell |
-29,500
| Closed | -$820K | – | 5666 |
|
|
2015
Q3 | $820K | Buy |
29,500
+22,700
| +334% | +$715K | 0.01% | 1390 |
|
|
2015
Q2 | $167K | Sell |
6,800
-1,400
| -17% | -$28.8K | ﹤0.01% | 2670 |
|
|
2015
Q1 | $150K | Sell |
8,200
-9,400
| -53% | -$191K | ﹤0.01% | 2607 |
|
|
2014
Q4 | $325K | Buy |
+17,600
| New | +$209K | ﹤0.01% | 1892 |
|
Group One Trading's LJPC Position: Q3 2022 in Review
Group One Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 333 shares — an estimated $1K sold.
Group One Trading first reported a position in LJPC in Q2 2015 and held it in 19 quarters. The position peaked at $366K in Q3 2015. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Group One Trading reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 333 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $1K.
- Group One Trading first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 19 quarters.
- Group One Trading's La Jolla Pharmaceutical Company position peaked at $366K in Q3 2015.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.